Twentyeight-Seven Therapeutics logo

Twentyeight-Seven Therapeutics jobs and careers

About Twentyeight-Seven Therapeutics

Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.

Founded in 2016 by Frank Slack, George Daley, Piotr Sliz and Richard Gregory.

Founded
2016
Employees
11 to 50
Total funding
$80M

Jobs at Twentyeight-Seven Therapeutics

No open positions right now. Explore more companies on TheJobsMap.